http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-880501-L
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-06 |
| filingDate | 1988-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1988-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-880501-L |
| titleOfInvention | Antihypercholesterolemic tetrazole |
| abstract | Compounds of formula (I), wherein R?1 and R?4 each are independently hydrogen, halogen, C1-4? alkyl, C1-4? alkoxy, or trifluoromethyl; R?2, R?3, R?5 and R?6 each are independently hydrogen, halogen, C1-4? alkyl or C1-4? alkoxy; tet is (II) or (III); n is an integer of from 0 to 2, inclusive; A is (IV) or (V); R?7 is hydrogen, C1-4? alkyl, C1-4? alkoxy(lower)alkyl or (2-methoxyethoxy)methyl; X is -OH or =O; and R?8 is hydrogen, a hydrolyzable ester group or a cation to form a non-toxic pharmaceutically acceptable salt, are novel antihypercholesterolemic agents which inhibit cholesterol biosynthesis. Intermediates and processes for their preparation are disclosed.n[WO8806584A1] |
| priorityDate | 1987-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 311.